Menu: Home :: go to Journal :: switch to Russian :: switch to English
You are here: all Journals and Issues→ Journal→ Issue→ Article

Conventional osteosarcoma

Annotation

Osteosarcoma (OS) - a malignant bone tumor that arises from bone-forming mesenchyme and characterized by production of osteoid and atypical bone structures proliferating malignant tumor cells. OS cells arise from multipotential mesenchymal nature, capable of differentiating into cartilage or bone direction. Although the OS detects signs often chondrosarcoma and fibrosarcoma, all these tumors, and in the first place, the operating system must be strictly differentiate between them. OS etiology is unknown in most cases. The most common site of the operating system are long bones. The majority (about 80 %) of the operating system develops in the metaphysis of long bones of the knee area (distal metaphysis of the femur, proximal metaphysis tibial and fibula) and the proximal metaphysis of the humerus. These parts of the skeleton are physiologically most responsible for the growth of the skeleton; it is here that occur most active growth processes of bone formation; and, apparently, they also represent a high probability of malignant transformation. For the diagnosis of OS is critical comparison of radiographic lesion with morphological changes, or rather, the mandatory analysis of X-ray pictures before analysis of histological or cytological preparations. On the basis of aggregate data identify several clinicopathological variants of the OS. There are now also being investigated OC at the genetic level in order to develop more effective treatments for this tumor, since 5-year survival rate for metastatic dissemination is extremely low (20-25 %).

Keywords

osteosarcoma; osteoid; primary bone sarcoma

Full-text in one file

Download

UDC

616-006

Pages

130-136

References

1. Hameed M., Dorfman H. Primary malignant bone tumors-recent developments // Semin. Diagn. Pathol. 2011. V. 28 (1). P. 86-101. 2. Fletcher C.D.M., Bridge J.A., Hogendoorn P.C.W., Mertens F. WHO Classification of Tumors of Soft Tissue and Bone. 4th Edition. 2013. P. 281-296. 3. Unni K.K., Inwards C.Y. Dahlin’s Bone Tumors. LIPPINCOTT, USA, 2010. P. 122-154. 4. Mirabello L., Troisi R.J., Savage S.A. International osteosarcoma incidence patterns in children and adolescents, middle ages, and elderly persons // Int. J. Cancer. 2009. V. 125 (1). P. 229-234. 5. Mirabello L., Troisi R.J., Savage S.A. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program // Cancer. 2009. V. 115 (7). P. 1531-1543. 6. Ando K., Heymann M.F., Stresing V., Mori K., Rédini F., Heymann D. Current therapeutic strategies and novel approaches in osteosarcoma // Cancers (Basel). 2013. V. 5 (2). P. 591-616. 7. Worch J., Matthay K.K., Neuhaus J., Goldsby R., DuBois S.G. Osteo-sarcoma in children 5 years of age or younger at initial diagnosis // Pe-diatr. Blood Cancer. 2010. V. 55 (2). P. 285-289. 8. Okada A., Hatori M., Hosaka M., Watanuki M., Itoi E. Secondary osteosarcoma arising after treatment for childhood hematologic malig-nancies // Ups. J. Med. Sci. 2009. V. 114 (4). P. 249-255. 9. Nielsen G.P., Rosenberg A.E., Deshpande V., Hornicek F.J., Kattapu-ram S.V., Rosenthal D.I. Diagnostic Pathology Bone. AMIRSYS, Can-ada, 2013. P. 2-21. 10. Mirabello L., Pfeiffer R., Murphy G., Daw N.C., Patiño-Garcia A., Troisi R.J., Hoover R.N., Douglass C., Schüz J., Craft A.W., Savage S.A. Height at diagnosis and birth-weight as risk factors for osteosar-coma // Cancer Causes Control. 2011. June. V. 22 (6). Р. 899-908. 11. Arndt C.A., Rose P.S., Folpe A.L., Laack N.N. Common Musculoske-letal Tumors of Childhood and Adolescence // Mayo Clin. Proc. 2012. V. 87 (5). P. 475-487. 12. Calvert G.T., Randall R.L., Jones K.B., Cannon-Albright L., Lessnick S., Schiffman J.D. Review article. At-risk populations for osteo-sarcoma: the syndromes and beyond // Sarcoma. 2012. Article ID 152382. 9 p. 13. Wang S., Shi H., Yu Q. Osteosarcoma of the jaws: demographic and CT imaging features // Dentomaxillofacial Radiology. 2012. V. 41 (1). P. 37-42. 14. Guillon M.A., Mary P.M., Brugière L., Marec-Bérard P., Pacquement H.D., Schmitt C., Guinebretière J.M., Tabone M.D. Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases // BMC Cancer. 2011. V. 11. Р. 407. 15. Urakawa H., Tsukushi S., Tsurudome I., Hirata A., Arai E., Kozawa E., Futamura N., Miyahara R., Ishiguro N., Nishida Y. Metastasis of osteosarcoma to stomach made clinically evident by hematemesis: a case report // World J. Surg. Oncol. 2013. V. 11. Р. 48. 16. Letourneau P.A., Xiao L., Harting M.T., Lally K.P., Cox C.S. Jr., Andrassy R.J., Hayes-Jordan A.A. Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome // J. Pediatr. Surg. 2011. V. 46 (7). P. 1333-1337. 17. Nagarajan R., Kamruzzaman A., Ness K.K., Marchese V.G., Sklar C., Mertens A., Yasui Y., Robison L.L., Marina N. Twenty years of follow-up of survivors of childhood osteosarcoma: a report from the Child-hood Cancer Survivor Study // Cancer. 2011. V. 117 (3). P. 625-634. 18. Li X., Ashana A.O., Moretti V.M., Lackman R.D. The relation of tumor necrosis and survival in patients with osteosarcoma // Int. Orthop. 2011. V. 35 (12). P. 1847-1853. 19. Lammli J., Fan M., Rosenthal H.G., Patni M., Rinehart E., Vergara G., Ablah E., Wooley P.H., Lucas G., Yang S.Y. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical os-teosarcoma // Int. Orthop. 2012. V. 36 (11). P. 2307-2313. 20. Rastogi S., Kumar R., Sankineani S.R., Marimuthu K., Rijal L., Pra-kash S., Jalan D., Khan S.A., Sharma M.C. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study // Int. Orthop. 2012. V. 36 (11). P. 2315-2321. 21. de Andrea C.E., Petrilli A.S., Jesus-Garcia R., Bleggi-Torres L.F., Alves M.T. Large and round tumor nuclei in osteosarcoma: good clini-cal outcome // Int. J. Clin. Exp. Pathol. 2011. V. 4 (2). P. 169-174. 22. Isakoff M.S., Barkauskas D.A., Ebb D., Morris C., Letson G.D. Poor survival for osteosarcoma of the pelvis. A report from the Children’s Oncology Group // Clin. Orthop. Relat. Res. 2012. V. 470 (7). P. 2007-2013. 23. Hingorani P., Seidel K., Krailo M., Mascarenhas L., Meyers P., Mari-na N., Conrad E.U., Hawkins D.S. Body Mass Index (BMI) at diagno-sis is associated with surgical wound complications in patients with localized osteosarcoma: A report from the Children’s Oncology Group // Pediatr. Blood Cancer. 2011. V. 57 (6). P. 939-942. 24. Wu X., Cheng B., Cai Z.D., Lou L.M. Determination of the apoptotic index in osteosarcoma tissue and its relationship with patients prognosis // Cancer Cell Intern. 2013. V. 13 (1). Р. 56. 25. Picci P., Manfrini M., Fabbri N., Gambarotti M., Vanel D. Atlas of musculoskeletal tumors and tumorlike lesions. Berlin: The Rizzoli Case Archive, 2014. P. 65-68. 26. Picci P. et al. Atlas of musculoskeletal tumors and tumorlike lesions. Berlin: The Rizzoli Case Archive, 2012–2013. P. 40-45.

Received

2015-01-14

Section of issue

Scientific articles

Для корректной работы сайта используйте один из современных браузеров. Например, Firefox 55, Chrome 60 или более новые.